Summary
- Current Price
- As of today, NGEN price is $3.64, down -2.41% on
- Current Price All-Time High
- NGEN price is currently -42.22% below its historical high of $6.30 set on
- Market Cap
- NGEN current market cap is $295M, up +58.12% over the past 365 days
- PE Ratio
- NGEN PE ratio is unknown
- Revenue
- NGEN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for NGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | NervGen Pharma Corp. |
| Ticker | NASDAQ: NGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | nervgen.com |
| Employees | 7 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.64 | ||
| Price, 1D Change | -2.41% | |
| $295M | ||
| - | ||
| - | ||
| 1.44 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.44 | ||
| EPS, 1Y Change | -67.69% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.44 | ||
| EPS Estimate | N/A | -$0.29 |
| EPS Est. Change | N/A | +33.91% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $3.64 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.24 | -$0.44 | -80.37% | |
| -$0.29 | N/A | +33.91% | |
| -$0.38 | N/A | +13.06% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +40.54% | ||
| +208.47% | ||
| +58.12% | ||
| +321.63% | ||
| 0.00% | ||
| 0.00% | ||
| -67.69% | ||
| -44.39% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.64 | ||
| $3.60 | ||
| SMA 200 vs Price | -1.18% | |
| $3.94 | ||
| SMA 50 vs Price | +8.37% | |
| 1.44 | ||
| $0.22 | ||
| 41.41 | ||
| 47.58% | ||
| 92.87% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.44 | ||
| -$39.90K | ||
| - | ||
| -$17.95M | ||
| - | ||
| -$31.57M | ||
| - | ||
| -$17.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 1.16 | ||
| 1.16 | ||
| - | ||
| - | ||
| 0.09 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 116.13 | ||
| -15.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $2.54M | ||
| $16.11M | ||
| $16.93M | ||
| $16.63M | ||
| $14.40M | ||
| $14.40M | ||
| $6,100.00 | ||
| $6,100.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $31.57M | ||
| $17.91M | ||
| $39.90K | ||
| $0.00 | ||
| $39.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$13.96M | ||
| $72.20K | ||
| $17.01M | ||
| $0.00 | ||
| -$13.96M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with NGEN
FAQ
What is the ticker symbol for NervGen Pharma Corp.?
The ticker symbol for NervGen Pharma Corp. is NASDAQ:NGEN
Does NervGen Pharma Corp. pay dividends?
No, NervGen Pharma Corp. does not pay dividends
What sector is NervGen Pharma Corp. in?
NervGen Pharma Corp. is in the Healthcare sector
What industry is NervGen Pharma Corp. in?
NervGen Pharma Corp. is in the Biotechnology industry
What country is NervGen Pharma Corp. based in?
NervGen Pharma Corp. is headquartered in Canada
When did NervGen Pharma Corp. go public?
NervGen Pharma Corp. initial public offering (IPO) was on February 8, 2021
Is NervGen Pharma Corp. in the S&P 500?
No, NervGen Pharma Corp. is not included in the S&P 500 index
Is NervGen Pharma Corp. in the NASDAQ 100?
No, NervGen Pharma Corp. is not included in the NASDAQ 100 index
Is NervGen Pharma Corp. in the Dow Jones?
No, NervGen Pharma Corp. is not included in the Dow Jones index
When was NervGen Pharma Corp. last earnings report?
NervGen Pharma Corp.'s most recent earnings report was on April 2, 2026
When does NervGen Pharma Corp. report earnings?
The next expected earnings date for NervGen Pharma Corp. is May 14, 2026
Data Sources & References
- NGEN Official Website www.nervgen.com
- NGEN Profile on Yahoo Finance finance.yahoo.com/quote/NGEN
- NGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ngen